While treatment with serum immunoglobulin IgG from SLE patients or IFN-α causes a reduction in Gpx4 and neutrophil death, blockade of IFN-α resumes the survival of neutrophils (Figure 1). Here, GPX4 is linked to systemic lupus erythematosus.